{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T22:34:00Z","timestamp":1761863640455},"reference-count":89,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","theclinics.com","clinicalkey.com.au","clinicalkey.fr","liver.theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Liver Disease"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1016\/j.cld.2016.12.005","type":"journal-article","created":{"date-parts":[[2017,1,31]],"date-time":"2017-01-31T07:15:57Z","timestamp":1485846957000},"page":"303-319","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Challenges in Renal Failure Treatment Before Liver Transplant"],"prefix":"10.1016","volume":"21","author":[{"given":"Fabrizio","family":"Fabrizi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Piergiorgio","family":"Messa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cld.2016.12.005_bib1","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1053\/j.ajkd.2011.12.032","article-title":"Hepatorenal syndrome: a severe, but treatable, cause of kidney failure in cirrhosis","volume":"59","author":"Fagundes","year":"2012","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.cld.2016.12.005_bib2","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1002\/hep.22605","article-title":"Acute kidney injury in cirrhosis","volume":"48","author":"Garcia-Tsao","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2016.12.005_bib3","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1053\/jhep.2003.50084","article-title":"Acute renal failure in patients with cirrhosis: perspectives in the age of MELD","volume":"37","author":"Moreau","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2016.12.005_bib4","doi-asserted-by":"crossref","first-page":"S93","DOI":"10.1016\/j.jhep.2008.01.010","article-title":"Pathogenesis and management of hepatorenal syndrome in patients with cirrhosis","volume":"48","author":"Angeli","year":"2008","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cld.2016.12.005_bib5","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/0016-5085(93)90031-7","article-title":"Incidence, predictive factors, and prognosis of the hepatorenal syndrome in cirrhosis and ascites","volume":"105","author":"Gines","year":"1993","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cld.2016.12.005_bib6","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1053\/j.gastro.2010.07.043","article-title":"Prognostic importance of the cause of renal failure in patients with cirrhosis","volume":"140","author":"Martin-Llahi","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cld.2016.12.005_bib7","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1002\/lt.23384","article-title":"Impact of the aetiology of acute kidney injury on outcomes following liver transplantation: acute tubular necrosis versus hepatorenal syndrome","volume":"18","author":"Nadim","year":"2012","journal-title":"Liver Transpl"},{"key":"10.1016\/j.cld.2016.12.005_bib8","series-title":"Tratado practico de las Enfermedades del Higado, de los Vasos Hepaticos y de las Vias Biliares","author":"Frerichs","year":"1877"},{"key":"10.1016\/j.cld.2016.12.005_bib9","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1097\/00000441-186304000-00002","article-title":"Clinical report on hydro-peritoneum, based on analysis of forty-six cases","volume":"45","author":"Flint","year":"1863","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.cld.2016.12.005_bib10","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1001\/archsurg.1939.01200100028003","article-title":"Occurrence, distribution, and pathogenesis of so called liver death and\/or hepatorenal syndrome","volume":"38","author":"Wilenski","year":"1939","journal-title":"Arch Surg"},{"key":"10.1016\/j.cld.2016.12.005_bib11","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1097\/00000658-193910000-00015","article-title":"Liver trauma and the hepatorenal syndrome","volume":"110","author":"Orr","year":"1939","journal-title":"Ann Surg"},{"key":"10.1016\/j.cld.2016.12.005_bib12","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/S0140-6736(56)90149-0","article-title":"Electrolyte and circulatory changes in terminal liver failure","volume":"271","author":"Hecker","year":"1956","journal-title":"Lancet"},{"key":"10.1016\/j.cld.2016.12.005_bib13","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1056\/NEJM196906192802501","article-title":"Transplantation of cadaveric kidneys from patients with hepatorenal syndrome. Evidence for the functional nature of renal failure in advanced liver disease","volume":"280","author":"Koppel","year":"1969","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cld.2016.12.005_bib14","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0002-9343(70)80073-0","article-title":"Renal failure in the patient with cirrhosis. The role of active vasoconstriction","volume":"49","author":"Epstein","year":"1970","journal-title":"Am J Med"},{"key":"10.1016\/j.cld.2016.12.005_bib15","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/S0140-6736(80)91298-2","article-title":"Hepatorenal syndrome or hepatic nephropathy?","volume":"315","author":"Anonimous","year":"1980","journal-title":"Lancet"},{"key":"10.1016\/j.cld.2016.12.005_bib16","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1002\/hep.510230122","article-title":"Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis","volume":"23","author":"Arroyo","year":"1996","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2016.12.005_bib17","first-page":"1310","article-title":"Diagnosis, prevention, and treatment of hepatorenal syndrome in cirrhosis","volume":"56","author":"Salerno","year":"2007","journal-title":"Gut"},{"key":"10.1016\/j.cld.2016.12.005_bib18","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.2215\/CJN.01340406","article-title":"Hepatorenal syndrome: pathophysiology and management","volume":"1","author":"Wadei","year":"2006","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.cld.2016.12.005_bib19","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1002\/hep.1840080532","article-title":"Peripheral arterial vasodilatation hypothesis: a proposal for the initiation of renal sodium and water retention in cirrhosis","volume":"8","author":"Schrier","year":"1988","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2016.12.005_bib20","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1007\/s12072-008-9109-7","article-title":"Cirrhotic cardiomyopathy","volume":"3","author":"Wong","year":"2009","journal-title":"Hepatol Int"},{"key":"10.1016\/j.cld.2016.12.005_bib21","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1016\/j.jhep.2014.12.029","article-title":"Diagnosis and management of acute kidney injury in patients with cirrhosis: revised consensus recommendations of the International Club of Ascites","volume":"62","author":"Angeli","year":"2015","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cld.2016.12.005_bib22","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.jhep.2010.11.020","article-title":"Predictors of response to terlipressin plus albumin in hepatorenal syndrome type 1: relationship of serum creatinine to hemodynamics","volume":"55","author":"Boyer","year":"2011","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cld.2016.12.005_bib23","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.jhep.2012.03.015","article-title":"Urinary neutrophil gelatinase \u2013associated lipocalin as biomarkers in the differential diagnosis of impairment of kidney function in cirrhosis","volume":"57","author":"Fagundes","year":"2012","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cld.2016.12.005_bib24","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1159\/000355739","article-title":"Hepatorenal syndrome and novel advances in its management","volume":"37","author":"Fabrizi","year":"2013","journal-title":"Kidney Blood Press Res"},{"key":"10.1016\/j.cld.2016.12.005_bib25","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1097\/00007890-199102000-00030","article-title":"Long-term survival and renal function following liver transplantation in patients with and without hepatorenal syndrome- experience in 300 cases","volume":"51","author":"Gonwa","year":"1991","journal-title":"Transplantation"},{"key":"10.1016\/j.cld.2016.12.005_bib26","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1681\/ASN.V42129","article-title":"The kidney in liver transplantation","volume":"4","author":"Distant","year":"1993","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.cld.2016.12.005_bib27","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1002\/lt.21149","article-title":"Hepatorenal syndrome: a proposal for kidney after liver transplantation","volume":"13","author":"Ruiz","year":"2007","journal-title":"Liver Transpl"},{"key":"10.1016\/j.cld.2016.12.005_bib28","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1093\/ndt\/gfh930","article-title":"Vasopressin, not octreotide, may be beneficial in the treatment of hepatorenal syndrome: a retrospective study","volume":"20","author":"Kiser","year":"2005","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.cld.2016.12.005_bib29","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/hep.510270107","article-title":"Reversibility of hepatorenal syndrome by prolonged administration of ornipressin and plasma volume expansion","volume":"27","author":"Guevara","year":"1998","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2016.12.005_bib30","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1002\/hep.510300430","article-title":"Long-term therapy and retreatment of hepatorenal syndrome type 1 with ornipressin and dopamine","volume":"30","author":"Gulberg","year":"1999","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2016.12.005_bib31","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/S0168-8278(99)80025-7","article-title":"Octreotide in the treatment of hepatorenal syndrome in cirrhotic patients","volume":"30","author":"Kaffy","year":"1999","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cld.2016.12.005_bib32","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1053\/jhep.2003.50276","article-title":"Octreotide in hepatorenal syndrome: a novel randomized, double-blind, placebo-controlled, crossover study","volume":"38","author":"Pomier-Layrargues","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2016.12.005_bib33","first-page":"174","article-title":"Reversal of type-1 hepatorenal syndrome with the administration of midodrine and octreotide","volume":"30","author":"Angeli","year":"1999","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2016.12.005_bib34","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1007\/s10620-006-9312-0","article-title":"Octreotide\/midrodrine therapy significantly improve renal function and 30-day survival in patients with type 1 hepatorenal syndrome","volume":"52","author":"Esrailian","year":"2007","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.cld.2016.12.005_bib35","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1097\/00003246-199501000-00031","article-title":"Reversal of hepatorenal syndrome with the combination of norephrine and dopamine","volume":"23","author":"Durkin","year":"1995","journal-title":"Crit Care Med"},{"key":"10.1016\/j.cld.2016.12.005_bib36","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1053\/jhep.2002.34343","article-title":"Effects of noradrenalin and albumin in patients with type 1 hepatorenal syndrome. A pilot study","volume":"36","author":"Duvoux","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2016.12.005_bib37","doi-asserted-by":"crossref","first-page":"e107466","DOI":"10.1371\/journal.pone.0107466","article-title":"Terlipressin versus norepinephrine in the treatment of hepatorenal syndrome: a systematic review and meta-analysis","volume":"9","author":"Nasar","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.cld.2016.12.005_bib38","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.jhep.2003.09.019","article-title":"Effects of treatment of hepatorenal syndrome before transplantation on post-transplantation outcome. A case-control study","volume":"40","author":"Restuccia","year":"2004","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cld.2016.12.005_bib39","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1111\/j.1365-2036.2006.03086.x","article-title":"Meta-analysis: terlipressin therapy for the hepatorenal syndrome","volume":"24","author":"Fabrizi","year":"2006","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cld.2016.12.005_bib40","first-page":"1054","article-title":"Hepatorenal syndrome. Long-term treatment with terlipressin as a bridge to liver transplantation","volume":"41","author":"Ganne-Carie","year":"1996","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.cld.2016.12.005_bib41","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S0168-8278(98)80151-7","article-title":"Beneficial effects of the 2-day administration of terlipressin in patients with cirrhosis and hepatorenal syndrome","volume":"29","author":"Hadengue","year":"1998","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cld.2016.12.005_bib42","first-page":"268","article-title":"Treatment with terlipressin as a bridge to liver transplantation in a patient with hepatorenal syndrome","volume":"61","author":"Le Moine","year":"1998","journal-title":"Acta Gastroenterol Belg"},{"key":"10.1016\/j.cld.2016.12.005_bib43","doi-asserted-by":"crossref","first-page":"2984","DOI":"10.1111\/j.1572-0241.2000.03214.x","article-title":"Hepatorenal syndrome in cirrhotic patients: terlipressin is a safe and efficient treatment; propanolol and digital treatment: precipitating and preventing factors?","volume":"95","author":"Duhamel","year":"2000","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cld.2016.12.005_bib44","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0168-8278(00)80158-0","article-title":"Terlipressin plus albumin infusion: an effective and safe therapy of hepatorenal syndrome","volume":"33","author":"Uriz","year":"2000","journal-title":"J\u00a0Hepatol"},{"issue":"1","key":"10.1016\/j.cld.2016.12.005_bib45","first-page":"15","article-title":"Long-term terlipressin administration improves renal function in cirrhotic patients with type 1 hepatorenal syndrome: a pilot study","volume":"64","author":"Mulkay","year":"2001","journal-title":"Acta Gastroenterol Belg"},{"key":"10.1016\/j.cld.2016.12.005_bib46","first-page":"123","article-title":"Efficacy of terlipressin in the treatment of liver cirrhosis with hepatorenal syndrome","volume":"7","author":"Yang","year":"2001","journal-title":"J Inter Intensive Med"},{"key":"10.1016\/j.cld.2016.12.005_bib47","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1053\/jhep.2002.35819","article-title":"Terlipressin therapy with and without albumin for patients with hepatorenal syndrome: results of a prospective, non randomised study","volume":"36","author":"Ortega","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2016.12.005_bib48","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1097\/00042737-200202000-00009","article-title":"Effect of terlipressin (glypressin) on hepatorenal syndrome in cirrhotic patients: results of a multicentre pilot study","volume":"14","author":"Halimi","year":"2002","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.cld.2016.12.005_bib49","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1046\/j.1440-1746.2002.02816.x","article-title":"Clinical course, predictive factors, and prognosis in patients with cirrhosis and type 1 hepatorenal syndrome treated with terlipressin: a retrospective analysis","volume":"17","author":"Colle","year":"2002","journal-title":"J\u00a0Gastroenterol Hepatol"},{"key":"10.1016\/j.cld.2016.12.005_bib50","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1053\/gast.2002.32364","article-title":"Terlipressin in patients with cirrhosis and type 1 hepatorenal syndrome: a retrospective multicenter study","volume":"122","author":"Moreau","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cld.2016.12.005_bib51","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1136\/gut.50.1.90","article-title":"Comparison of the effect of terlipressin and albumin on arterial blood volume in patients with cirrhosis and tense ascites treated by paracentesis: a randomised pilot study","volume":"50","author":"Moreau","year":"2002","journal-title":"Gut"},{"key":"10.1016\/j.cld.2016.12.005_bib52","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1097\/00042737-200212000-00013","article-title":"Renal failure in cirrhotic patients: role of terlipressin in clinical approach to hepatorenal syndrome type 2","volume":"14","author":"Alessandria","year":"2002","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.cld.2016.12.005_bib53","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1097\/00042737-200308000-00015","article-title":"Terlipressin plus hydroxyethyl starch infusion: an effective treatment for hepatorenal syndrome","volume":"15","author":"Saner","year":"2003","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.cld.2016.12.005_bib54","first-page":"78","article-title":"Terlipressin and gelafundin: safe therapy of hepatorenal syndrome","volume":"9","author":"Saner","year":"2004","journal-title":"Eur J Med Res"},{"key":"10.1016\/j.cld.2016.12.005_bib55","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1111\/j.1440-1746.2005.03902.x","article-title":"Effects of somatostatin, terlipressin and somatostatin plus terlipressin on portal and systemic hemodynamics and renal sodium excretion in patients with cirrhosis","volume":"20","author":"Kalambokis","year":"2005","journal-title":"J\u00a0Gastroenterol Hepatol"},{"key":"10.1016\/j.cld.2016.12.005_bib56","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.jhep.2011.02.002","article-title":"Continuous recurrence of type 1 hepatorenal syndrome and long-term treatment with terlipressin and albumin: a new exception to MELD score in the allocation system to liver transplantation?","volume":"55","author":"Piano","year":"2011","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cld.2016.12.005_bib57","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.dld.2010.08.001","article-title":"Long-term treatment of hepatorenal syndrome as a bridge to liver transplantation","volume":"43","author":"Caraceni","year":"2011","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.cld.2016.12.005_bib58","first-page":"454","article-title":"A\u00a0case of peripheral ischemic complication after terlipressin therapy","volume":"47","author":"Lee","year":"2006","journal-title":"Korean J Gastroenterol"},{"key":"10.1016\/j.cld.2016.12.005_bib59","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1111\/j.1572-0241.2005.40952.x","article-title":"Hepatorenal syndrome: a dreaded complication of end-stage liver disease","volume":"100","author":"Cardenas","year":"2005","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cld.2016.12.005_bib60","doi-asserted-by":"crossref","first-page":"4978","DOI":"10.3748\/wjg.v18.i36.4978","article-title":"Hepatorenal syndrome","volume":"28","author":"Lata","year":"2012","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.cld.2016.12.005_bib61","doi-asserted-by":"crossref","first-page":"S393","DOI":"10.1179\/acb.2007.088","article-title":"Recent advances in the management of hepatorenal syndrome","volume":"62","author":"Fabrizi","year":"2007","journal-title":"Acta Clin Belg"},{"key":"10.1016\/j.cld.2016.12.005_bib62","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1046\/j.1440-1746.2003.02934.x","article-title":"Beneficial effects of terlipressin in hepatorenal syndrome: a prospective, randomized placebo-controlled clinical trial","volume":"18","author":"Solanki","year":"2003","journal-title":"J\u00a0Gastroenterol Hepatol"},{"key":"10.1016\/j.cld.2016.12.005_bib63","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1007\/s10620-007-9919-9","article-title":"Terlipressin and albumin in patients with cirrhosis and type I hepatorenal syndrome","volume":"53","author":"Neri","year":"2008","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.cld.2016.12.005_bib64","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1053\/j.gastro.2008.02.024","article-title":"Terlipressin and albumin vs. albumin in patients with cirrhosis and hepatorenal syndrome: a randomized study","volume":"134","author":"Martin-Llahi","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cld.2016.12.005_bib65","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1053\/j.gastro.2008.02.014","article-title":"A\u00a0randomized, prospective, double-blind, placebo-controlled trial of terlipressin for type 1 hepatorenal syndrome","volume":"134","author":"Sanyal","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cld.2016.12.005_bib66","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1053\/j.gastro.2016.02.026","article-title":"Terlipressin plus albumin is more effective than albumin alone in improving renal function in patients with cirrhosis and hepatorenal syndrome type 1","volume":"150","author":"Boyer","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cld.2016.12.005_bib67","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1177\/039139880903200303","article-title":"Terlipressin for hepatorenal syndrome: a meta-analysis of randomized trials","volume":"32","author":"Fabrizi","year":"2009","journal-title":"Int J Artif Organs"},{"key":"10.1016\/j.cld.2016.12.005_bib68","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1002\/hep.23286","article-title":"Systematic review of randomized trials on vasoconstrictor drugs for hepatorenal syndrome","volume":"51","author":"Gluud","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2016.12.005_bib69","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1002\/hep.28396","article-title":"Terlipressin given by continuous intravenous infusion versus intravenous boluses in the treatment of hepatorenal syndrome: a randomized controlled study","volume":"63","author":"Cavallin","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2016.12.005_bib70","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1053\/j.ajkd.2011.07.017","article-title":"Therapeutic response to vasoconstrictors in hepatorenal syndrome parallels increase in mean arterial pressure: a pooled analysis of clinical trials","volume":"58","author":"Velez","year":"2011","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.cld.2016.12.005_bib71","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.jhep.2007.04.010","article-title":"Noradrenalin versus terlipressin in patients with hepatorenal syndrome: a prospective, randomized, unblinded, pilot study","volume":"47","author":"Alessandria","year":"2007","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cld.2016.12.005_bib72","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1572-0241.2008.01828.x","article-title":"An open label, pilot, randomized controlled trial of noradrenaline versus terlipressin in the treatment of type 1 hepatorenal syndrome and predictors of response","volume":"103","author":"Sharma","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cld.2016.12.005_bib73","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/j.jhep.2012.01.012","article-title":"Noradrenalin vs. terlipressin in the treatment of hepatorenal syndrome: a randomized study","volume":"56","author":"Singh","year":"2012","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cld.2016.12.005_bib74","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1111\/liv.12179","article-title":"Noradrenaline versus terlipressin in the treatment of type 2 hepatorenal syndrome: a randomized pilot study","volume":"33","author":"Ghosh","year":"2013","journal-title":"Liver Int"},{"key":"10.1016\/j.cld.2016.12.005_bib75","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1136\/gut.2009.193227","article-title":"TIPS for the treatment of refractory ascites, hepatorenal syndrome and hepatic hydrothorax: a critical update","volume":"59","author":"Rossle","year":"2010","journal-title":"Gut"},{"key":"10.1016\/j.cld.2016.12.005_bib76","first-page":"666","article-title":"Acute renal failure treatment in liver cirrhosis: the role of transjugular intrahepatic portosystemic shunts","volume":"18","author":"Holl\u00f2","year":"2001","journal-title":"G\u00a0Ital Nefrol"},{"key":"10.1016\/j.cld.2016.12.005_bib77","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1002\/hep.510280219","article-title":"Transjugular intrahepatic portosystemic shunt in hepatorenal syndrome: effects on renal function and vasoactive systems","volume":"28","author":"Guevara","year":"1998","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2016.12.005_bib78","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1136\/gut.47.2.288","article-title":"Long term outcome after transjugular intrahepatic portosystemic stent-shunt in non-transplant cirrhotics with hepatorenal syndrome: a phase 2 study","volume":"47","author":"Brensing","year":"2000","journal-title":"Gut"},{"key":"10.1016\/j.cld.2016.12.005_bib79","first-page":"1753","article-title":"Type-2 hepatorenal syndrome and refractory ascites: role of of transjugular intra-hepatic portosystemic stent-shunt in eighteen patients with advanced cirrhosis awaiting orthotopic liver transplantation","volume":"50","author":"Testino","year":"2000","journal-title":"Hepatogastroenterology"},{"key":"10.1016\/j.cld.2016.12.005_bib80","first-page":"203","article-title":"Severe acute alcoholic hepatitis and hepatorenal syndrome: role of transjugular portosystemic stent shunt","volume":"5","author":"Testino","year":"2012","journal-title":"J\u00a0Med Life"},{"key":"10.1016\/j.cld.2016.12.005_bib81","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1159\/000334149","article-title":"The challenges of providing renal replacement therapy in decompensated liver cirrhosis","volume":"33","author":"Gonwa","year":"2012","journal-title":"Blood Purif"},{"key":"10.1016\/j.cld.2016.12.005_bib82","doi-asserted-by":"crossref","first-page":"135","DOI":"10.3109\/08860229509026250","article-title":"Risk factors and outcome of 107 patients with decompensated liver disease and acute renal failure: the role of haemodialysis","volume":"17","author":"Keller","year":"1995","journal-title":"Ren Fail"},{"key":"10.1016\/j.cld.2016.12.005_bib83","first-page":"S245","article-title":"Effect of renal replacement therapy on patients with combined acute renal and fulminant hepatic failure","volume":"41","author":"Davenport","year":"1993","journal-title":"Kidney Int"},{"key":"10.1016\/j.cld.2016.12.005_bib84","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1097\/00007890-200105270-00012","article-title":"Renal replacement therapy and orthotopic liver transplantation: the role of continuous veno-venous haemodialysis","volume":"71","author":"Gonwa","year":"2001","journal-title":"Transplantation"},{"key":"10.1016\/j.cld.2016.12.005_bib85","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1111\/j.1440-1746.2004.03471.x","article-title":"Which patients benefit from haemodialysis therapy in hepatorenal syndrome?","volume":"19","author":"Witzke","year":"2004","journal-title":"J\u00a0Gastroenterol Hepatol"},{"key":"10.1016\/j.cld.2016.12.005_bib86","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1002\/lt.500060326","article-title":"Improvement of hepatorenal syndrome with extracorporeal albumin dialysis MARS: results of a prospective, randomized, controlled clinical trial","volume":"6","author":"Mitzner","year":"2002","journal-title":"Liver Transpl"},{"key":"10.1016\/j.cld.2016.12.005_bib87","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1136\/gut.2008.174615","article-title":"Molecular adsorbent recirculating system is ineffective in the management of type 1 hepatorenal syndrome in patients with cirrhosis and ascites who have failed vasoconstrictor treatment","volume":"59","author":"Wong","year":"2010","journal-title":"Gut"},{"key":"10.1016\/j.cld.2016.12.005_bib88","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1111\/jgh.12159","article-title":"Impact of molecular adsorbent recirculating system on renal recovery in type-1 hepatorenal syndrome patients with chronic liver failure","volume":"28","author":"Lavayssiere","year":"2013","journal-title":"J\u00a0Gastroenterol Hepatol"},{"key":"10.1016\/j.cld.2016.12.005_bib89","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1016\/j.transproceed.2006.02.017","article-title":"Prometheus system: a technological support in liver failure","volume":"38","author":"Santoro","year":"2006","journal-title":"Transplant Proc"}],"container-title":["Clinics in Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089326116301131?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089326116301131?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,23]],"date-time":"2022-07-23T02:13:11Z","timestamp":1658542391000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1089326116301131"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5]]},"references-count":89,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,5]]}},"alternative-id":["S1089326116301131"],"URL":"https:\/\/doi.org\/10.1016\/j.cld.2016.12.005","relation":{},"ISSN":["1089-3261"],"issn-type":[{"value":"1089-3261","type":"print"}],"subject":[],"published":{"date-parts":[[2017,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Challenges in Renal Failure Treatment Before Liver Transplant","name":"articletitle","label":"Article Title"},{"value":"Clinics in Liver Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cld.2016.12.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}